Menu

Articles by : Shannon Young, Associate Editor/Senior Writer

LA Times Says ‘No’ to California Ballot Measure That Would Affect 340B 

Shannon Young, Associate Editor/Senior Writer Views
The Los Angeles Times’ editorial board endorsed the “no” position on Proposition 34, a 340B-realated measure which will appear on the Nov. 5 ballot.
An influential California newspaper recently urged against a November ballot measure, which would require certain healthcare providers in the state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: New Filings in Missouri, Minnesota

Shannon Young, Associate Editor/Senior Writer Views
Key motions were recently filed in state contract pharmacy litigation in Missouri and Minnesota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Health Leader Slams J&J Rebate Proposal, Urges Providers to ‘Remain Vigilant’ in Op-Ed

Shannon Young, Associate Editor/Senior Writer Views
Maureen Testoni, the president and CEO of 340B Health celebrated J&J’s retreat from a 340B rebate proposal in an Oct. 9 RACmonitor op-ed.
The head of an influential 340B hospital advocacy group claimed “victory” in the recent fight against Johnson & Johnson’s (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Providers Raise Caution on Claims Data Submission Requirements After 340B ESP Terms of Use Update Continues to Defer to Manufacturers

Shannon Young, Associate Editor/Senior Writer Views
Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
Editor’s Note: An earlier version of this story incorrectly suggested that an Oct. 4 update to 340B ESP’s terms of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Orders and Filings in Arkansas, Louisiana, Kansas, Mississippi Maryland, Missouri

Shannon Young, Associate Editor/Senior Writer Views
Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

Shannon Young, Associate Editor/Senior Writer Views
Sally Pipes, the president and CEO of the drug-industry funded Pacific Research Institute, criticized pushback that led Johnson & Johnson to forgo its plans to implement a 340B rebate model in an Oct. 7 Forbes op-ed.
The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Lawmakers Hit Campaign Trail Without Unveiling Highly Anticipated SUSTAIN 340B Act

Shannon Young, Associate Editor/Senior Writer Views
The “Group of Six” is expected to announce this week that it plans to release the SUSTAIN Act by the end of the year.
Members of Congress are headed back to their districts this week to campaign ahead of the November elections without unveiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates

Shannon Young, Associate Editor/Senior Writer Views
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

AHA Op-Ed Takes Aim at ‘Big Pharma’s’ 340B Program Growth Rhetoric 

Shannon Young, Associate Editor/Senior Writer Views
American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
A major hospital group recently hit back against the drug industry’s claims that hospital behavior has helped drive “out of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: AbbVie Asks 5th Circuit to Reverse Ruling, New Developments in Missouri and Kansas 

Shannon Young, Associate Editor/Senior Writer Views
Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live